| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 15th December 2020 | Steve Aselage | 5,549 | Open or private sale | $26.02 | $144,384.98 |
| 6th November 2020 | Steve Aselage | 20,625 | Open or private sale | $23.00 | $474,375.00 |
| 5th November 2020 | Steve Aselage | 2,500 | Open or private sale | $21.26 | $53,150.00 |
| 12th October 2020 | William T. Andrews | 37,500 | Disposition due to a tender of shares in a change of control transaction | $18.15 | $680,625.00 |
| 31st August 2020 | Steve Aselage | 2,409 | Grant/award etc. | $4.15 | $9,997.35 |
| 5th August 2020 | Steve Aselage | 2,500 | Open or private sale | $19.68 | $49,200.00 |
| 24th July 2020 | Steve Aselage | 45,000 | Open or private purchase | $3.50 | $157,500.00 |
| 24th July 2020 | Chris Schelling | 142,857 | Open or private purchase | $3.50 | $499,999.50 |
| 24th July 2020 | John Michael Dunn | 21,428 | Open or private purchase | $3.50 | $74,998.00 |
| 24th July 2020 | Donald Joseph | 14,285 | Open or private purchase | $3.50 | $49,997.50 |
Opexa Therapeutics
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Ticker: OPXA
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1069308
Employees:
Exchange: None
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.